| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| IMC-1C11 |
➤ Sign Up |
Method and compositions for treating cancerous tumors |
|
➤ Sign Up |
| IMC-1C11 |
➤ Sign Up |
Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
Chemaphor Inc. (Ontario, CA) |
➤ Sign Up |
| IMC-1C11 |
➤ Sign Up |
5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors |
Vertex Pharmaceuticals Incorporated (Cambridge, MA) |
➤ Sign Up |
| IMC-1C11 |
➤ Sign Up |
Compositions and methods relating to anti-IGF-1 receptor antibodies |
Amgen Inc. (Thousand Oaks, CA) |
➤ Sign Up |
| IMC-1C11 |
➤ Sign Up |
Compositions and methods for cancer immunotherapy |
Eisai R&D Management Co., Ltd. (Bunkyo-Ku, Tokyo, JP) |
➤ Sign Up |
| IMC-1C11 |
➤ Sign Up |
Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer |
STC.UNM (Albuquerque, NM) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
